The Food and Drug Administration has approved a generic drug for arthritis made by Watson Pharmaceuticals, the company said.

A pill developed by AstraZeneca and Pozen that combines a nonsteroidal anti-inflammatory drug with a proton-pump inhibitor was well-tolerated in patients with osteoarthritis, according to a new study.

A Food and Drug Administration advisory committee has voted to recommend expanding the use of...